Sionna Therapeutics Income Statement (2024-2026) | SION

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026	Jun2026
Shares Outstanding (Entity) (Quarter)										45.16M
Operating items
Research & Development (Quarter)	10.22M	8.23M	24.58M	14.25M	13.67M	15.38M	16.04M	15.17M	18.96M	21.86M
Selling, General & Administrative (Quarter)	2.93M	3.06M	3.40M	3.88M	5.99M	6.52M	7.76M	8.44M	10.64M	10.61M
Operating Expenses (Quarter)										32.47M
Other Operating Expenses (Quarter)						0.17M				-0.00M
Operating Income (Quarter)										-32.47M
EBIT (Quarter)										-32.47M
Non-operating items
Interest & Investment Income (Quarter)										2.59M
Other Non Operating Income (Quarter)	0.17M	0.17M	0.19M	0.17M	0.18M	0.17M	0.07M
Non Operating Income (Quarter)										2.58M
Net income details
EBT (Quarter)										-29.88M
Profit After Tax (Quarter)										-30.25M
Income from Continuing Operations (Quarter)										-29.88M
Consolidated Net Income (Quarter)										-29.88M
Income towards Parent Company (Quarter)										-29.88M
Net Income towards Common Stockholders (Quarter)										-29.88M
Additional items
EPS (Basic) (Quarter)										-0.66
EPS (Diluted) (Quarter)										-0.66
Shares Outstanding (Quarter)										45.15M
Shares Outstanding (Diluted) (Quarter)										45.15M
EBITDA (Quarter)										-32.47M
Interest Expenses (Quarter)				51.61M				168.01M